• Study on Brigatinib and Durvalumab for Patients with Unresectable Stage III Non-Small Cell Lung Cancer with ALK Gene Change After Chemotherapy and Radiation Therapy

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    France Italy Poland Spain
  • Study on the Safety and Tolerance of BI 1291583 in Adults with Cystic Fibrosis Bronchiectasis

    Not recruiting

    2 1 1
    Investigated Diseases:
    Belgium France Germany Italy The Netherlands Spain
  • Study on the Safety and Effects of Setanaxib for Patients with Alport Syndrome

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Czechia France Lithuania Slovakia Spain
  • Study on Izokibep for Patients with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Hungary Poland Spain
  • Long-Term Study on Aflibercept for Retinopathy of Prematurity in Infants

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Czechia Greece Italy Portugal +4
  • Study on Soticlestat for Children and Adults with Dravet or Lennox-Gastaut Syndrome Previously Treated with Fenfluramine

    Not recruiting

    3 1 1
    Investigated Drugs:
    Denmark
  • Study on the Safety of Epcoritamab for Children and Young Adults with Relapsed or Refractory Aggressive B-cell Lymphomas

    Not recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia France Germany Italy Spain
  • Study on the Safety and Effectiveness of GEN3017 for Patients with Relapsed or Refractory Hodgkin and Non-Hodgkin Lymphoma

    Not recruiting

    2 1 1 1
    Denmark France Germany Italy The Netherlands
  • Study of Romiplostim Treatment for Chemotherapy-induced Low Blood Platelets in Adults with Gastrointestinal, Pancreatic, or Colorectal Cancer Receiving Oxaliplatin Chemotherapy

    Not recruiting

    3 1 1
    Investigated Drugs:
    Bulgaria France Greece Italy Poland Portugal +2
  • Study on the Safety and Effects of Lutetium (177Lu) Vipivotide Tetraxetan in Patients with Advanced Prostate Cancer and Different Levels of Kidney Function

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    France Germany Italy Spain

powered by